624 656
prostatectomy (RP) on margin status and biochemical failure. Eur
Urol 2005;47:176–84
.
[23]
McLaughlin PW, Evans C, Feng M, Narayana V. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys 2010;76:369–78.
[24]
Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 2016;375:1425–37.
[25]
Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367: 203–13.
[26]
Resnick MJ, Koyama T, Fan K-H, et al. Long-term functional out- comes after treatment for localized prostate cancer. N Engl J Med 2013;368:436–45.[27] Morris WJ, Tyldesley S, Rodda S, et al. *ASCENDE-RT: an analysis of
survival endpoints for a randomized trial comparing a low-dose-
rate brachytherapy boost to a dose-escalated external beam boost
for high-and intermediate-risk prostate cancer. Int J Radiat Oncol
Biol Phys. In press.
http://dx.doi.org/10.1016/j.ijrobp.2016.11.026 .[28]
Spratt DE, Pei X, Yamada J, Kollmeier MA, Cox B, Zelefsky MJ. Long- term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate can- cer. Int J Radiat Oncol Biol Phys 2013;85:686–92.
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 6 1 7 – 6 2 4
624